Table 1.
Sample number for array CGH analysis and incidence of clonal heterogeneity for each types of lymphoma
| Type of lymphoma | Total sample number | Number of samples without CNA | Samples with CNA | |
|---|---|---|---|---|
| Number of samples with CNA (number of samples with clonal heterogeneity) | Clonal heterogeneity (%) | |||
| MCL | 29 | 0 | 29 (20) | 69% |
| DLBCL | 117 | 0 | 117 (55) | 47% |
| FL | 79 | 13 | 66 (19) | 29% |
| BL | 25 | 5 | 20 (5) | 25% |
| MALT | 31 | 21 | 10 (3) | 30% |
| PTCL-NOS | 51 | 12 | 39 (16) | 41% |
| Total | 332 | 51 | 281 (118) | 42% |
CGH, comparative genomic hybridization; CNA, copy number alterations; BL, Burkitt lymphoma; DLBCL, diffuse large B-cell lymphoma; FL, follicular lymphoma; MALT, mucosa-associated lymphoid tissue lymphoma; MCL, mantle cell lymphoma; PTCL-NOS, peripheral T-cell lymphoma, not otherwise specified.